Asthma

Treatment Phase: First-line prevention

Clinical criteria:

  • The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.

Population criteria:

  • Patient must be aged 2 to 5 years inclusive.

Clinical criteria:

  • The condition must be frequent intermittent; OR

  • The condition must be mild persistent,

AND

  • The treatment must be the single preventer agent,

AND

  • The treatment must be an alternative to sodium cromoglycate; OR

  • The treatment must be an alternative to nedocromil sodium.

Note

This drug is not PBS-subsidised for use in a child aged 2 to 5 years with moderate to severe asthma. It is not intended as an alternative for a child aged 2 to 5 years who requires a corticosteroid as a preventer medication.

Note

This drug is not subsidised in a child aged 2 to 5 years for use in combination with other preventer medications. PBS subsidy for this drug will therefore cease for a child aged 2 to 5 years who requires a preventer medication in addition to this drug.

Note

No increase in the maximum quantity or number of units may be authorised.

Note

No increase in the maximum number of repeats may be authorised.